First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT) Shares Down 0.3% – What’s Next?

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBTGet Free Report)’s stock price traded down 0.3% during mid-day trading on Wednesday . The company traded as low as GBX 1,906.20 and last traded at GBX 1,906.20. 157 shares traded hands during trading, a decline of 98% from the average session volume of 8,712 shares. The stock had previously closed at GBX 1,912.80.

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Price Performance

The company has a market cap of £781.95 million and a price-to-earnings ratio of -1,732.91. The firm has a 50-day moving average price of GBX 1,843.62 and a 200 day moving average price of GBX 1,645.20.

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Company Profile

(Get Free Report)

Forbidden Technologies plc develops and owns cloud-based video technology in the United Kingdom, North America, and internationally. It offers Forscene, a cloud based video post-production and publishing platform with various applications, such as editing, adding closed caption, graphics, metadata fast, remote viewing, collaboration, and publishing content.

Featured Stories

Receive News & Ratings for First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation and related companies with MarketBeat.com's FREE daily email newsletter.